About Us

Our Ethos
Pebble offers a proprietary, state-of-the-art LIVING-ORGAN system to researchers aiming to develop tangible healthcare products and innovations. Line-of-sight to patients is important to us, and sits closely with our strong moral objective to make a difference. We will continually strive to improve our LIVING-ORGAN system models and will bespoke-build systems based on a researcher’s needs – this is often the best part of the job!
We will maintain our strong 3R’s ethos (Reduction, Refinement and Replacement of small animals in research), and offer an ethical alternative to large animal research. Our approach guarantees that no laboratory animals are used. Instead, we support local farmers in rearing pigs to the highest husbandry standards, using only surplus biological material. This is important, not only ethically, but also to ensure that we have full provenance of our biological material.
Our Pipeline
We are a high knowledge and innovative company. Inherently, we are developing our own products and therapies across three business units. Our pipeline includes a broad range of perfusion and preservation solutions, protocols and systems, and first-in-class blood purification systems for leukocytes, cytokines, complement components and electrolytes.

The Management Board

CEO & Chief Scientist
Prof James Fildes

COO
Mark Claydon

CFO
Richard Smith

Non-Executive Director
Doug Stellman

Non-Executive Director
Dr Thierry Jean
The Scientists

CSO
Prof James Fildes

Principal Scientist
Dr John Stone

Principal Scientist
Dr Tim Entwistle

Academic Surgeon
Mr Kavit Amin

Research Scientist
William Cowey

Research Scientist
Amy Stewart

Research Technician
Corban Bowers

Research Technician
Emily Milburn

Research Technician
Georgie Chesworth

Research Technician
Ann-Marie Jessop

Research Technician
Sam Slough

Research Technician
Jack Heywood